Minnetronix Medical, Inc., a leading medical technology company, today announced that the company’s President, Jeremy Maniak, will succeed founder Richard Nazarian as CEO on February 1, 2020.
Minnetronix Neuro Launches Global Neurapheresis™ Research Consortium
Collaborative effort will accelerate development of novel therapies for underserved diseases involving the central nervous system
Minnetronix Neuro Successfully Completes First Clinical Study in Hemorrhagic Stroke
Minnesota-based Company to Present at Late Breaking Session during Congress of Neurological Surgeons
Contract med-tech manufacturer Minnetronix to launch own device
Minnetronix is developing a product that removes contaminants in the cerebral spinal fluid after a hemorrhagic stroke.
Minnetronix Maintains Perfect Record with Seventh FDA Inspection
Minnetronix, maintaining our perfect record, has now undergone seven successful FDA Quality System Inspection Technique (QSIT) inspections with No Action…
Let’s talk about Media opportunities.
Call 612-578-2834 or email beth@LaBreche.com
We are here to help